GTS Securities’s Elevation Oncology ELEV Stock Holding History

GTS Securities’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300,029	Closed	-$110K	–	1485
2025 Q2	$110K	Buy	+300,029	New	+$100K	﹤0.01%	1159

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

GTS Securities's ELEV Position: Q3 2025 in Review

GTS Securities sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 300,029 shares — an estimated $110K sold.

GTS Securities first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $110K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

GTS Securities reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
GTS Securities sold 300,029 Elevation Oncology shares in Q3 2025, an estimated $110K.
GTS Securities first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
GTS Securities's Elevation Oncology position peaked at $110K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.